Company/Division name | Medicines for All Institute |
Type of work | Manufacturing |
If manufacturing, is the company a contract manufacturer? | Yes |
Reshoring category: | Reshoring |
Year reshoring announced: | 2021 |
Year reshoring implemented or to be implemented: | 2023 |
Domestically, the work will be done: | In-house |
City reshored to: | Petersburg |
State(s) reshored to: | VA |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | pharmaceutical ingredients, sedatives, antibiotics |
What domestic positive factors made reshoring more attractive? | Government Incentives, Other, import replacement, Covid-19, national stockpile |
Government Incentive dollar amount: | $354 million |